| Fri, 27 Mar 2020 18:54:43: | Experts float Roche stroke drug Activase as potential COVID-19 therapy
|
| Fri, 27 Mar 2020 15:26:55: | Coronavirus delays Bluebird Bio gene therapy Zynteglo’s EU launch, U.S. filing
|
| Fri, 27 Mar 2020 15:09:46: | Drug supplies, costs hurt by unintended consequences of COVID-19 policies, suppliers tell White House
|
| Fri, 27 Mar 2020 14:02:02: | After 'initial shock,' generics supply chain likely to weather COVID-19 blows: analyst
|
| Fri, 27 Mar 2020 13:42:39: | Intercept's hotly anticipated NASH drug has to wait for its FDA hearing, thanks to COVID-19
|
| Fri, 27 Mar 2020 13:19:01: | New dashboard tracks top COVID-19 content among life sciences companies, influencers and media
|
| Fri, 27 Mar 2020 11:36:14: | FiercePharmaAsia—Chloroquine COVID-19 trial, import leniency, export ban; BeiGene’s Abraxane woe
|
| Thu, 26 Mar 2020 15:01:26: | Xellia starts sterile injectable production at once vilified U.S. plant
|
| Thu, 26 Mar 2020 14:49:00: | Did chloroquine really fail a COVID-19 study—or was the trial design to blame?
|
| Thu, 26 Mar 2020 13:11:54: | Should Biogen's Spinraza for SMA be delayed amid COVID-19? No, say these parents
|
| Thu, 26 Mar 2020 12:47:11: | Pfizer, Mylan say COVID-19 delays will postpone their Viatris merger
|
| Wed, 25 Mar 2020 20:28:25: | Bristol Myers nabs long-sought FDA nod for Celgene's MS drug ozanimod, but pandemic delays launch
|
| Wed, 25 Mar 2020 18:50:24: | A tale of 2 meetings: Amid pandemic, ASCO moves online while ADA plows ahead
|
| Wed, 25 Mar 2020 18:23:49: | Biohaven embraces digital to keep migraine launch on track despite COVID-19
|
| Wed, 25 Mar 2020 18:23:17: | Gilead asks FDA to rescind remdesivir orphan drug tag after public backlash
|
| Wed, 25 Mar 2020 16:16:47: | India denies the export of the drug Trump keeps touting for COVID-19
|
| Wed, 25 Mar 2020 15:20:58: | BeiGene's supply of Bristol Myers Squibb's Abraxane freezes in China amid Fresenius Kabi plant woes
|
| Wed, 25 Mar 2020 14:39:19: | Merck KGaA beats out Novartis with targeted lung cancer nod for Tepmetko in Japan
|
| Wed, 25 Mar 2020 14:25:12: | Jefferies pumping $10M into ApiJect and HHS' national syringe 'surge' network
|
| Wed, 25 Mar 2020 13:58:46: | #FierceMadness: AbbVie's Skyrizi, Novartis' Zolgensma in the hunt for Sweet 16
|
| Wed, 25 Mar 2020 13:31:50: | Novartis escapes one set of kickback allegations, but federal charges roll on
|
| Wed, 25 Mar 2020 13:30:45: | White House working on platform to track patient outcomes for off-label COVID-19 drugs: NYT
|
| Tue, 24 Mar 2020 23:36:40: | Trump's flipped his view on pharma companies thanks to COVID-19. Will the public?
|
| Tue, 24 Mar 2020 18:42:56: | Teva CEO Schultz took a big pay cut last year—but he bagged a contract extension, too
|
| Tue, 24 Mar 2020 15:19:53: | Top COVID-19 aspirants chloroquine, AbbVie's Kaletra and a flu drug disappoint in clinical tests
|
